source
- SystImmune/BMS and Hengrui showcase ADC data for EGFR-mutant lung cancer at ESMOAt the European Society for Medical Oncology (ESMO) meeting in Madrid, Li Zhang of Sun Yat-sen University Cancer Center presented early data from the HERON‑Lung01 study, highlighting an antibody‑dr…
- FDA Commissioner Highlights New Rare Disease Framework Emphasizing Patient VoiceActing US Food and Drug Administration (FDA) Commissioner Kyle Diamantas highlighted the agency's new rare disease framework during a fireside chat at the NORD Breakthrough Summit. The framework i…